Show simple item record

dc.creatorSiminoff, LA
dc.creatorTraino, HM
dc.creatorMosavel, M
dc.creatorBarker, L
dc.creatorGudger, G
dc.creatorUndale, A
dc.date.accessioned2021-02-03T17:58:36Z
dc.date.available2021-02-03T17:58:36Z
dc.date.issued2016-01-01
dc.identifier.issn1098-3600
dc.identifier.issn1530-0366
dc.identifier.doihttp://dx.doi.org/10.34944/dspace/5791
dc.identifier.other25856669 (pubmed)
dc.identifier.urihttp://hdl.handle.net/20.500.12613/5809
dc.description.abstract© 2016 American College of Medical Genetics and Genomics. Purpose:There are many ethical considerations regarding the return of genetic results to biobanking participants, especially when biobanks collect samples from deceased organ and tissue donors that require the authorization of a family decision maker (FDM). This article explores FDM knowledge and opinions regarding return of genetic results in the context of the Genotype-Tissue Expression (GTEx) Project, which does not return results to participants.Methods:Data collection included a survey completed by Organ Procurement Organization requesters (n = 22) and semistructured telephone interviews with FDM (n = 55).Results:Nearly every FDM wanted some form of genetic results returned. Information regarding treatable diseases (94.3%) and diseases that could affect their children (84.9%) were more desirable than that regarding untreatable diseases (71.7%). Sixty percent of FDMs understood that GTEx would not return genetic results. FDMs were four times more likely to have correct knowledge of the GTEx policy when their GTEx requester reported discussing the topic with them.Conclusion:FDMs from the GTEx project were interested in receiving genetic test results. Marked changes in the infrastructure of the GTEx would be required to alter the policy. Regardless, care must be taken to ensure that the return policy is clearly communicated with FDMs to dispel misconceptions.
dc.format.extent82-88
dc.language.isoen
dc.relation.haspartGenetics in Medicine
dc.relation.isreferencedbySpringer Science and Business Media LLC
dc.subjectbiobanking
dc.subjectbioethical issues
dc.subjectgenetic research
dc.subjectincidental findings
dc.subjectreturn of results
dc.titleFamily decision maker perspectives on the return of genetic results in biobanking research
dc.typeArticle
dc.type.genreJournal Article
dc.relation.doi10.1038/gim.2015.38
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.creator.orcidGardiner, Heather Marie|0000-0003-2017-991X
dc.creator.orcidSiminoff, Laura|0000-0002-6775-665X
dc.date.updated2021-02-03T17:58:33Z
refterms.dateFOA2021-02-03T17:58:36Z


Files in this item

Thumbnail
Name:
Family decision maker perspectives ...
Size:
121.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record